MindMed (MNMD) Stock Falls After Reverse Stock Split
MindMed's price should be less volatile after its 1-for-15 reverse stock split, making it less interesting to speculators
Stay updated with breaking news from Jake Freeman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MindMed's price should be less volatile after its 1-for-15 reverse stock split, making it less interesting to speculators
They borrow shares in exchange for a fee, then sell them. If the shares do fall, the short seller buys them back and returns them to their owner.
They borrow shares in exchange for a fee, then sell them. If the shares do fall, the short seller buys them back and returns them to their owner.
Even before his headline-making windfall thanks to Bed Bath & Beyond, Jake Freeman was no ordinary zoomer. Read more here.
MindMed (MNMD) announced early Thursday that it had begun its phase 2b trial for its Generalized Anxiety Disorder (GAD) drug MM-120. Shares of the psy